Home
|
About IJMPO
|
Editorial board
|
Search
|
Ahead of print
|
Current Issue
|
Archives
|
Instructions
|
Subscribe
|
Advertise
|
Contact us
|
Reader Login
Search Article
Advanced search
Users Online: 554
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2016| January-March | Volume 37 | Issue 1
Online since
February 19, 2016
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
ORIGINAL ARTICLES
Chemotherapy-induced adverse drug reactions in oncology patients: A prospective observational survey
Deepti Chopra, Harmeet S Rehan, Vibha Sharma, Ritu Mishra
January-March 2016, 37(1):42-46
DOI
:10.4103/0971-5851.177015
PMID
:27051157
Background:
Chemotherapy, a multimodal approach to oncological treatment, involves highly complex regimens and hence accounts to high susceptibility toward adverse drug reactions (ADRs). The present study aims to determine the prevalence of adverse events in patients treated with chemotherapy.
Materials and Methods:
Spontaneous ADR report of patients on antineoplastic drugs received in the past 2 years (January 2011-January 2013) were studied. These reports were analyzed for various carcinomas under treatment, medications used, types of ADRs, organ system involvement, severity, causality assessment, and preventability.
Results:
Over a period of 2 years, a total 591 cases were received with an incidence of 58.6%. The prevalence of ADRs was more in female patients (73.6%) as compared to men. ADRs mostly occurred in the age group of 41-50 years (27.4%). Patients treated for breast carcinoma (39.1%) reported the highest incidence of ADRs. Cisplatin (19.6%) was found to be the most common offending drug. The most common ADR reported was nausea and vomiting (23%). Gastroenterology (40.1%) was the most affected system. About 50.2% of the ADRs required treatment and 12.9% ADRs were considered serious. Causality assessment revealed that 80% of the ADRs were possible. About 86.97% cases were found to be mild, and 51% were not preventable.
Conclusion:
The success of chemotherapy comes with the word of caution regarding toxicities of antineoplastic drugs. Pharmacovigilance of these drugs needs to be explored, and use of preventative measures needs to be enhanced in order to reduce the incidence and severity of ADRs.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
3,123
784
-
Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia
Akash Shah, Prasanth Ganesan, Venkatraman Radhakrishnan, Krishnarathinam Kannan, Rejiv Rajendranath, Vandana Mahajan, Varalakshmi Vijayakumar, Trivadi Ganesan, Tenali Gnana Sagar
January-March 2016, 37(1):53-58
DOI
:10.4103/0971-5851.177032
PMID
:27051159
Background:
Antifungal prophylaxis (AFP) reduces the incidence of invasive fungal infections (IFIs) during induction therapy of acute myeloid leukemia (AML). Posaconazole is considered the standard of care. Voriconazole, a generic cheaper alternative is a newer generation azole with broad anti-fungal activity. There is limited data on the use of voriconazole as a prophylactic drug.
Materials and Methods:
A single-center, prospective study was performed during which patients with AML undergoing induction chemotherapy received voriconazole as AFP (April 2012 to February 2014). Outcomes were compared with historical patients who received fluconazole as AFP (January 2011-March 2012,
n
= 66).
Results:
Seventy-five patients with AML (median age: 17 years [range: 1-75]; male:female 1.6:1) received voriconazole as AFP. The incidence of proven/probable/possible (ppp) IFI was 6.6% (5/75). Voriconazole and fluconazole cohorts were well-matched with respect to baseline characteristics. Voriconazole (when compared to fluconazole) reduced the incidence of pppIFI (5/75, 6.6% vs. 19/66, 29%;
P
< 0.001), need to start therapeutic (empiric + pppIFI) antifungals (26/75, 34% vs. 51/66, 48%;
P
< 0.001) and delayed the start of therapeutic antifungals in those who needed it (day 16 vs. day 10;
P
< 0.001). Mortality due to IFI was also reduced with the use of voriconazole (1/75, 1.3% vs. 6/66, 9%;
P
= 0.0507), but this was not significant. Three patients discontinued voriconazole due to side-effects.
Conclusion:
Voriconazole is an effective and safe oral agent for IFI prophylaxis during induction therapy of AML. Availability of generic equivalents makes this a more economical alternative to posaconazole.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
2,066
367
-
Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center
Vivek Bhat, Sudeep Gupta, Rohini Kelkar, Sanjay Biswas, Navin Khattry, Aliasgar Moiyadi, Prashant Bhat, Reshma Ambulkar, Preeti Chavan, Shubadha Chiplunkar, Amol Kotekar, Tejpal Gupta
January-March 2016, 37(1):20-24
DOI
:10.4103/0971-5851.177010
PMID
:27051152
Introduction:
This increased risk of bacterial infections in the cancer patient is further compounded by the rising trends of antibiotic resistance in commonly implicated organisms. In the Indian setting this is particularly true in case of Gram negative bacilli such as Escherichia coli, Klebsiella pneumoniae and Acinetobacter spp. Increasing resistance among Gram positive organisms is also a matter of concern. The aim of this study was to document the common organisms isolated from bacterial infections in cancer patients and describe their antibiotic susceptibilities.
Methods:
We conducted a 6 month study of all isolates from blood, urine, skin/soft tissue and respiratory samples of patients received from medical and surgical oncology units in our hospital. All samples were processed as per standard microbiology laboratory operating procedures. Isolates were identified to species level and susceptibility tests were performed as per Clinical Laboratory Standards Institute (CLSI) guidelines -2012.
Results:
A total of 285 specimens from medical oncology (114) and surgical oncology services (171) were cultured. Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Acinetobacter spp. were most commonly encountered. More than half of the Acinetobacter strains were resistant to carbapenems. Resistance in Klebsiella pneumoniae to cephalosporins, fluoroquinolones and carbapenems was >50%. Of the Staphylococcus aureus isolates 41.67% were methicillin resistant.
Conclusion:
There is, in general, a high level of antibiotic resistance among gram negative bacilli, particularly E. coli, Klebsiella pneumoniae and Acinetobacter spp. Resistance among Gram positives is not as acute, although the MRSA incidence is increasing.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,893
402
-
Hodgkin lymphoma: A clinicopathological and immunophenotypic study
Kaumudi Konkay, Tara Roshni Paul, Shantveer G Uppin, Digumarti Raghunadha Rao
January-March 2016, 37(1):59-65
DOI
:10.4103/0971-5851.177038
PMID
:27051160
Introduction:
The diagnosis of Hodgkin lymphoma (HL) is defined in terms of its microscopic appearance (histology) and the expression of cell surface markers (immunophenotype).
Aims and objectives:
This study aims to analyze the clinical features, histomorphology, and immunoprofile of over 200 patients of HL diagnosed over a period of 4 years at our institute and to determine relative frequency of various histological subtypes (based on WHO classification) in relation to age and sex distribution in this part of the country.
Materials and Methods:
All HL cases diagnosed between January 2006 and December 2009 were retrieved from hospital records. The histopathology of both lymph node and bone marrow biopsy (where ever available) along with immunohistochemistry (CD15, CD30, CD20, and ALK) were reviewed.
Results:
There was a bimodal age distribution. HL affected people a decade earlier than in the western population. The most common presenting complaint was cervical lymphadenopathy. Mixed cellularity was the most frequent subtype (67%), followed by nodular sclerosing subtype (23.5%). Group A (CD15+, CD30+, CD20−), which represents the archetypical immunophenotype of classical HL (CHL) was the most common type (60.6%). The number of CD15 negative CHL was 35.8% and CD20 positive CHL was 17.5%. CD15 negativity with CD20 positivity was seen in 5% CHL. One out of seven CD20 positive CHL patients showed relapse.
Conclusion:
In this paper, we have discussed in detail about various clinical and histopathological parameters of HL and their relative frequency in various histological subtypes. This paper is being presented as it is a rather large study from India taking into consideration the clinical, pathologic, and immunophenotypic profile of the patients.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,634
287
-
Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia
Ravi Sankar Arigela, Sadashivudu Gundeti, Ranga Raman Ganta, Srividhya Nasaka, Vijay Gandhi Linga, Lakshmi Srinivas Maddali
January-March 2016, 37(1):32-37
DOI
:10.4103/0971-5851.177013
PMID
:27051155
Aim:
In this study, we attempted to analyze the impact of insurance based health care system and treatment compliance on the outcome of adolescent and adults with acute lymphoblastic leukemia (ALL).
Materials and Methods:
Patients who underwent treatment for ALL during the period 2003-2011 were enrolled into this retrospective study. Patients on supportive or palliative care only and patients with age <10 years were excluded. The hospital records and tumor registry records were studied. Patients were stratified into two groups, Group A (prior to the introduction of state health insurance [SHI], 2003-2007) and Group B (after the introduction of SHI, 2008-2011). Overall survival (OS) was calculated using Kaplan-Meier method.
Results:
A total of 420 patients with suspected or confirmed ALL visited our center during the study period and 179 patients (87 in Group A and 92 in Group B) were considered for inclusion. The median age in years (range) was 18 (10-57) and 18 (10-58) respectively in Groups A and B with males more than females. Median OS (95% CI) was 9 (6.7-11.2) and 12 (7.3-16.7) months in the Groups A and B respectively (
P
= 0.265). Poor treatment compliance in both groups was high (36% in Group A and 41% in Group B, [
P
= 0.107]) with lower default rates in Group B (
P
= 0.019). Patients with good compliance in the total study population and the individual study groups had significantly better OS.
Conclusions:
Insurance based health care has improved outcomes in the present study but not compliance to treatment. Significantly better OS was observed in patients with good compliance.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,586
229
-
REVIEW ARTICLES
Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexus
Anita Spadigam, Anita Dhupar, Shaheen Syed, Tajindra Singh Saluja
January-March 2016, 37(1):6-13
DOI
:10.4103/0971-5851.177002
PMID
:27051150
The International Diabetes Federation Diabetes Atlas estimates a staggering 590 million people affected with diabetes mellitus (DM) within the next two decades globally, of which Type 2 DM will constitute more than 90%. The associated insulin resistance, hyperinsulinemia, and hyperglycemia pose a further significant risk for developing diverse malignant neoplasms. Diabetes and malignancy are multifactorial heterogeneous diseases. The immune dysfunction secondary to Type 2 diabetes also reactivates latent infections with high morbidity and mortality rates. Epstein-Barr virus (EBV), a ubiquitous human herpes virus-4, is an oncogenic virus; its recrudescence in the immunocompromised condition activates the expression of EBV latency genes, thus immortalizing the infected cell and giving rise to lymphomas and carcinomas. Extranodal natural killer/T-cell lymphoma (ENKTCL), common in South-East Asia and Latin America; is a belligerent type of non-Hodgkin lymphoma (NHL) almost invariably associated with EBV. An analysis of articles sourced from the PubMed database and Google Scholar web resource until February 2014, suggests an increasing incidence of NHL in Asia/India and of ENKTCL in India, over the last few decades. This article reviews the epidemiological evidence linking various neoplasms with Type 2 DM and prognosticates the emergence of ENKTCL as a common lymphoreticular malignancy secondary to Type 2 diabetes, in the Indian population in the next few decades.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,506
234
-
ORIGINAL ARTICLES
Vitamin D insufficiency among children with cancer in India
Ram Mohan, Gem Mohan, Julius Xavier Scott, Aruna Rajendran, Venkatraman Paramasivam, Manipriya Ravindran
January-March 2016, 37(1):14-19
DOI
:10.4103/0971-5851.177009
PMID
:27051151
Background:
Vitamin D plays an important role in regulating various homeostatic mechanisms and has yet untapped potential in cancer prevention and prognosis. Only a few studies have been done worldwide in relating the Vitamin D levels in pediatric cancer patients to the general population but none so far in an Indian setting to the best of our knowledge.
Objective:
To compare the Vitamin D levels in a group of children with cancer to that of the general pediatric population and to note differences in the prevalence of Vitamin D insufficiency and make inferences arising from demographic and therapeutic variations.
Materials and Methods:
Vitamin D levels were found by immuno-chemilumino-metric assay in 102 children (51 cases and 51 controls) over a 6 months period.
Results:
In comparing the Vitamin D levels of children with cancer and controls from a healthy population we found an increased incidence of Vitamin D insufficiency in cancer children (80.39%) when compared to controls (50.98%) and a much lower mean Vitamin D value in cancer children (22.8 ng/ml) when compared to controls (33 ng/dl). It was also found that cancer children above 6 years had a greater chance for developing Vitamin D insufficiency (
P
= 0.038) as did children suffering from hematological malignancies (
P
= 0.025).
Conclusion:
Our study showed an increased prevalence of Vitamin D insufficiency in children with cancer and hence we suggest routine measurement of Vitamin D levels in children with cancer and subsequent supplementation.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,433
278
-
REVIEW ARTICLES
Prostate cancer is not breast cancer
Ajit Venniyoor
January-March 2016, 37(1):4-5
DOI
:10.4103/0971-5851.176980
PMID
:27051149
Cancers of the prostate and breast are hormone dependent cancers. There is a tendency to equate them and apply same algorithms for treatment. It is pointed out that metastatic prostate cancer with bone-only disease is a potentially fatal condition with a much poorer prognosis than metastatic breast cancer and needs a more aggressive approach.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,353
243
-
EDITORIAL COMMENTARY
Molecular functional imaging in personalized clinical oncology: The road less traveled
Abhishek Mahajan, Subhash Desai, Ameya Shirish Kawthalkar, Meenakshi Haresh Thakur
January-March 2016, 37(1):1-3
DOI
:10.4103/0971-5851.176979
PMID
:27051148
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,365
225
-
ORIGINAL ARTICLES
Retrospective analysis of patients with carcinoma cervix in a rural/semi-urban setting in Western India
Ranvijay Singh, Nishitha Shetty, Maryam Naveed, Suraj B Pawar, Sindu Iska, Navya Reddy Alugubelli
January-March 2016, 37(1):25-27
DOI
:10.4103/0971-5851.177011
PMID
:27051153
Objectives:
To compare the presentation of cervical cancer and the treatment modalities received by the patients at a semi-urban/rural area of Western India with that of published literature from urban centers.
Materials and Methods:
We conducted a retrospective analysis of patients with cervical cancer who presented at a semi-urban/rural cancer center between 2010 and 2013. A total of 141 patients with the median age of 51 years (25-81) were studied. The demographic and clinical variables included age, annual family income, profession, comorbidities, baseline hemoglobin, prior screening, clinical stage, treatment administered, and complications. The pathological variables included tumor type and grade.
Results:
In our study, all patients presented with vaginal bleeding. Majority of the patients (51 patients, 37.7%) had Stage 3B disease. Since majority presented at later stages (Stage 3B), chemotherapy-radiotherapy was the most common treatment modality used in our population. On histopathology, 127 patients (90%) had squamous cell carcinoma while 14 patients (10%) had adenocarcinoma. In 96 patients (68%), the tumor grade was not known while it was a high, intermediate, and low grade in 6 (4%), 18 (13%), and 21 (15%) patients, respectively. The follow-up data of our study were not adequate; hence, the long-term survival results could not be presented.
Conclusion:
Patients in rural India setting present at later stages which could be improved by creating awareness, improving their personal hygiene, and adequate screening.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,265
201
-
Gestational trophoblastic neoplasia, management as per risk stratification in a developing country
Ansar Hussain, Aejaz Aziz Shiekh, Gul Mohd Bhat, AR Lone
January-March 2016, 37(1):28-31
DOI
:10.4103/0971-5851.177012
PMID
:27051154
Aims:
The purpose of this analysis was to address the outcome of GTN from a tertiary care centre of India.
Materials and Methods:
We undertook a retrospective and prospective review of GTN cases treated at our centre from 2006 to 2014. Patients of GTN were assigned to low-risk or high-risk categories as per the FIGO scoring system. The low-risk group was treated with combination of actinomycin-D and methotrexate (MTX) and the high-risk group received the EMA/CO regimen. Salvage therapy was EP/TP. Treatment was continued for 3 cycles after normalization of β-hCG level, after which the patients were kept on follow-up.
Results:
In total, 52 GTN patients were treated at our institution during this period; 21 were low-risk and 31 were in the high-risk category. The lung was the most common site of metastasis. All low risk patients achieved complete remission. Among high risk patients one patient died while receiving first cycle chemotherapy, one patient relapsed and 29 patients achieved complete remission. The single relapsed patient also achieved remission with 2nd line chemotherapy.
Conclusion:
1. Two drug combination of Actinomycin-D and Methotrexate is a better alternative to single drug chemotherapy especially in developing countries were proper risk stratification is not always possible. 2. Patients with high disease burden should initially be treated with low dose chemotherapy to avoid life threatening visceral haemorrhage.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,174
233
-
Fluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?
Sarbani Ghosh Laskar, Gunjan Baijal, Venkatesh Rangarajan, Nilendu Purandare, Manju Sengar, Sneha Shah, Tejpal Gupta, Ashwini Budrukkar, Vedang Murthy, Prathamesh S Pai, AK D'Cruz, JP Agarwal
January-March 2016, 37(1):47-52
DOI
:10.4103/0971-5851.177030
PMID
:27051158
Background:
Positron emission tomography-computed tomography (PET-CT) is an emerging modality for staging and response evaluation in carcinoma nasopharynx. This study was conducted to evaluate the impact of PET-CT in assessing response and outcomes in carcinoma nasopharynx.
Materials and Methods:
Forty-five patients of nonmetastatic carcinoma nasopharynx who underwent PET-CT for response evaluation at 10-12 weeks posttherapy between 2004 and 2009 were evaluated. Patients were classified as responders (Group A) if there was a complete response on PET-CT or as nonresponders (Group B) if there was any uptake above the background activity. Data regarding demographics, treatment, and outcomes were collected from their records and compared across the Groups A and B.
Results:
The median age was 41 years. 42 out of 45 (93.3%) patients had WHO Grade 2B disease (undifferentiated squamous carcinoma). 24.4%, 31.1%, 15.6, and 28.8% patients were in American Joint Committee on Cancer Stage IIb, III, Iva, and IVb. All patients were treated with neoadjuvant chemotherapy followed by concomitant chemoradiotherapy. Forty-five patients, 28 (62.2%) were classified as responders, whereas 17 (37.8%) were classified as nonresponders. There was no significant difference in the age, sex, WHO grade, and stage distribution between the groups. Compliance to treatment was comparable across both groups. The median follow-up was 25.3 months (759 days). The disease-free survival (DFS) of the group was 57.3% at 3 years. The DFS at 3 years was 87.3% and 19.7% for Group A and B, respectively (log-rank test,
P
< 0.001). Univariate and multivariate analysis revealed Groups to be the only significant factor predicting DFS (
P
value 0.002 and < 0.001, respectively). In Group B, the most common site of disease failure was distant (9, 53%).
Conclusion:
PET-CT can be used to evaluate response and as a tool to identify patients at higher risk of distant failure. Further, this could be exploited to identify patients who may need treatment intensification. This needs to be validated prospectively.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
1,189
183
-
A report of the frequency of colorectal carcinoma and involved lymph nodes in South-West Iran
Hodjatollah Shahbazian, Yaser Nasuri, Seyed Mohammad Hosseini, Shoaleh Arvandi, Samira Razzaghi
January-March 2016, 37(1):38-41
DOI
:10.4103/0971-5851.177014
PMID
:27051156
Context:
The colorectal cancer (CRC) is the most common malignancy between men and women. CRC has considerable morbidity and mortality, with more than 1000,000 new cases and 500,000 annual deaths. Regional lymph nodes are most common sites of metastasis from colon cancer. Lymph node involvement is an essential factor in enabling the accurate evaluation of prognosis in CRC patients.
Aims:
In this study, we focused on the frequency of CRC and involved lymph nodes and adequacy of lymph node dissection in patients who referred to the Oncology and Radiotherapy Department of Golestan Hospital in Ahvaz City located in South-West Iran.
Setting and Design:
We conducted a retrospective study among patients receiving surgical treatment for CRC in the Department of Oncology and Radiotherapy of Golestan Hospital in Ahvaz City located in South-West Iran between 2001 and 2010.
Methods and Materials:
All patients who underwent resection for CRC by open or laparoscopic approaches were included in the study. Data were collected from patients' medical records.
Statistical Analysis Used:
Statistical data were analyzed using SPSS 21.
Results:
A total of 585 cases with CRC aged from16 to 89 years with mean age of 53-year-old were studied. Average number of dissected nodes was 8 lymph nodes, and lymph nodes were not found in pathology specimen of 61 cases (10.4%). In 199 patients (34.01%), number of dissected lymph nodes was 12 or more and in 386 patients (65.98%), number of dissected lymph nodes was <12.
Conclusion:
This study revealed a large amount of patients that had been under over treatment with radiotherapy and the following inability. Lack of removal of sufficient tissue by the surgeon during surgery or an inadequate sample check by a pathologist might lead to an inability to correct staging of the disease as well as the inability to determine the treatment program of the patients and over treatment with radiotherapy and chemotherapy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
944
128
-
IMAGES IN ONCOLOGY
Adenomatoid tumor of cervix: The first case report
Tarak Banik, Krishnendu Mondal, Rupali Mandal
January-March 2016, 37(1):66-66
DOI
:10.4103/0971-5851.177039
PMID
:27051161
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
910
142
-
Isolated bone marrow carcinomatosis: A rare presentation of poorly differentiated adenocarcinoma of the stomach in a young male
Manoj Lakhotia, Hans Raj Pahadiya, Ronak Gandhi, Akanksha Choudhary, Ramesh Chand Purohit, Sukhdev Choudhary
January-March 2016, 37(1):67-67
DOI
:10.4103/0971-5851.177040
PMID
:27051162
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[PubMed]
820
118
-
Feedback
Subscribe
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© Indian Journal of Medical and Paediatric Oncology | Published by Wolters Kluwer -
Medknow
Online since 1
st
June, 2009